chronic liver diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: **18 years of age *Known chronic liver disease *Not on treatment for liver disease during study period *Written informed consent;Volunteers: *No history of liver disease *Written informed consent
Exclusion criteria
Exclusion criteria: Patients/Volunteers: *Under 18 years of age *Contra-indications for MRI scanning (use of standard MRI checklist, see document E4) *Treatment for liver disease *Use of medications known to have steatogenic effects on the liver: synthetic estrogens, corticosteroids, diltiazem, nifedipine, perhexilline, amiodarone, metformine, insulin, statins, rosglitazon, methotrexate, antiretroviral therapy, tamoxifen, tetracycline, valproate* *Known hemochromatosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The voxel-wise variability in elasticity measurements for patients and healthy volunteers for: * Repeated measurements during one scanning session * Same-day reproducibility * Reproducibility with a 2-4 week interval | — |
Countries
Netherlands